Effectiveness of dual cyclooxygense and leukotriene blockade with ibuprofen and LY203647 during canine endotoxic shock.

Abstract

Ibuprofen and the leukotriene antagonist, LY203647, were used to evaluate the effectiveness of LY203647 in the dual blockade of cyclooxygenase and leukotriene to maintain hemodynamic parameters in endotoxemia. Ibuprofen pretreatment alone or dual blockade (ibuprofen plus LY203647) protected blood pressure and renal blood flow at 1 and 3 hr after endotoxin infusion. Cardiac output at 1 hr after endotoxin in dogs treated with ibuprofen was slightly but significantly decreased. Dual pretreatment prevented this decrease at 1 hr; however, cardiac output was similar in both groups by 3 hr. Dual blockade administered after endotoxin induced increases in blood pressure and cardiac output at 3 hr. LY203647 pretreatment alone did not prevent the postendotoxemic declines in any measured parameters. The increased plasma SGOT and lactate of endotoxemia were exacerbated by LY203647 and blunted by ibuprofen treatment. We conclude that the addition of LY203647 to ibuprofen treatment offers no additional significant protection of hemodynamic parameters.

• Authors: J C Passmore, A E Jimenez
• Journal: Circulatory shock (Circ Shock) Vol. 39 Issue 1 Pg. 21-8 (Jan 1993) ISSN: 0092-6213 [Print] United States
• PMID: 8481974 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Acetophenones
• Blood Glucose
• Lactates
• SRS-A
• Tetrazoles
• LY 203647
• Lactic Acid
• Aspartate Aminotransferases
• Ibuprofen

Topics

• Acetophenones (pharmacology, therapeutic use)
• Acid-Base Equilibrium
• Animals
• Aspartate Aminotransferases (blood)
• Blood Glucose (analysis)
• Blood Pressure (drug effects)
• Dogs
• Glomerular Filtration Rate (drug effects)
• Ibuprofen (pharmacology, therapeutic use)
• Lactates (blood)
• Lactic Acid
• Renal Circulation (drug effects)
• SRS-A (antagonists & inhibitors)
• Shock, Septic (drug therapy, physiopathology)
• Tetrazoles (pharmacology, therapeutic use)